Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 17, Issue 8, 1999, Pages 2461-2470

  Thomas, Deborah A ^a   Cortes, Jorge ^a   O'Brien, Susan ^a   Pierce, Sherry ^a   Faderl, Stefan ^a   Albitar, Maher ^a   Hagemeister, Frederick B ^a   Cabanillas, Fernando F ^a   Murphy, Sharon ^a   Keating, Michael J ^a   Kantarjian, Hagop ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; B CELL LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENTAL DISEASE; NEUROTOXICITY; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0032812621     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.8.2461     Document Type: Article

References (40)

1. Bennett JM, Catovsky D, Daniel M-T, et al: Proposals for the classification of the acute leukaemias. Br J Hematol 33:451-458, 1976
2. Bloomfield CD, Goldman AI, Alimena G, et al: Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67:415-420, 1986
3. Faderl S, Kantarjian HM, Talpaz M, et al: Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 91:3995-4019, 1998
4. Hammami A, Chan WC, Michels SD, et al: Mature B-cell acute leukemia: A clinical, morphological, immunological, and cytogenetic study of nine cases. Hematologic Pathol 5:109-118, 1991
5. Finlay JL, Borcherding W: Acute B-lymphocytic leukemia with L1 morphology: A report of two pediatric cases. Leukemia 2:60-62, 1988
6. Gladstone B, Kadam PR, Balsara BR, et al: Cytogenetic studies on patients of acute lymphoblastic leukemia Burkitt's type with (8;14) & (14;18) translocations. Indian J Med Res 99:264-266, 1994
7. Stamatoullas A, Bastard C, Lesesve JF, et al: Acute B-cell leukemia with t(14;18). Blood 90:503, 1997 (abstr 2243)
8. Velangi M, Jackson G, Bown N, et al: Pattern of cytogenetics in the northern region 1983-1997. Br J Haematol 102:108, 1998 (abstr 425)
9. Baccarani M, Corbelli G, Amadori S, et al: Adolescent and adult lymphoblastic leukemia: Prognostic features and outcome of therapy - A study of 293 patients. Blood 60:677-684, 1982
10. Lazzarino M, Morra MJ, Alessandrino EP, et al: Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients. Eur J Cancer Clin Oncol 18:813-819, 1982
11. Kantarjian HM, Walters RS, Keating MJ, et al: Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard-and high-risk acute lymphocytic leukemia. J Clin Oncol 8:994-1004, 1990
12. Kantarjian HM, O'Brien S, Smith T, et al: Acute lymphocytic leukemia in the elderly: Characteristics and outcome with the vincristine-Adriamycin-dexamethasone (VAD) regimen. Br J Haematol 88:94-100, 1994
13. Gill PS, Meyer PR, Pavlova Z, et al: B cell acute lymphocytic leukemia in adults: Clinical, morphologic, and immunologic findings. J Clin Oncol 4:737-743, 1986
14. Bernasconi C, Brusamolino E, Pagnucco G, et al: Burkitt's lymphoma/leukemia: A clinico-pathologic study on 24 adult patients. Leukemia 5:90-94, 1991 (suppl 1)
15. Ostronoff M, Soussain C, Zambon E, et al: Burkitt's lymphoma in adults: A retrospective study of 46 cases. Nouv Rev Fr Hematol 34:389-397, 1992
16. Hoelzer D, Ludwig WD, Thiel E, et al: Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 87:495-508, 1996
17. Patte C, Philip T, Rodary C, et al: High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123-132, 1991
18. Patte C, Philip T, Rodary C, et al: Improved survival rate in children with stage III and stage IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 4:1219-1226, 1986
19. Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage - A report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 13:359-372, 1995
20. Reiter A, Schrappe M, Ludwig W-D, et al: Favourable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM Group. Blood 80:2471-2478, 1992
21. Hann IM, Eden OB, Barnes J, et al: 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukemia of childhood. Br J Haematol 76:359-364, 1990
22. Murphy SB, Bowman WP, Abromowitch M, et al: Results of the treatment of advanced-stage Burkitt's lymphoma and B cell (Sig+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 4:1732-1739, 1986
23. Bowman WP, Shuster JJ, Cook B, et al: Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group study. J Clin Oncol 14:1252-1261, 1996
24. Soussain C, Patte C, Ostronoff M, et al: Small noncleaved cell lymphoma and leukemia in adults: A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85:664-674, 1995
25. Fenaux P, Lai JL, Miaux O, et al: Burkitt cell acute leukaemia (L3 ALL) in adults: A report of 18 cases. Br J Haematol 71:371-376, 1989
26. Cortes J, Koller C, Thomas D, et al: Treatment of AIDS-related Burkitt's leukemia or lymphoma with the hyper-CVAD regimen. Blood 92:401, 1998 (abstr 1656)
27. Cortes J, O'Brien SM, Pierce S, et al: The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood 86:2091-2097, 1995
28. Kaplan EL, Meier P: Non-parametric estimation form incomplete observations. J Am Stat Assoc 53:457-481, 1965
29. Cox DR: Regression models and life tables. J R Stat Soc [B] 34:187-220, 1972
30. Kornblau SM, Goodacre A, Cabanillas F: Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literature. Hematol Oncol 9:63-78, 1991
31. Imamura N, Mtasiwa DM, Ota H, et al: FAB L3 type of B-cell acute lymphoblastic leukemia (B-ALL) without chromosome abnormalities. Am J Hematol 35:216-218, 1990
32. Advani Sh, Ahuya HG, Gopal R, et al: Clinical and phenotypic heterogeneity in L3-acute lymphoblastic leukemia. Indian J Cancer 25:108-113, 1988
33. Lai JL, Fenaux P, Zandecki M, et al: Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities. Ann Genet 32:26-32, 1989
34. Goldie JH, Coldman AJ: The genetic origin of drug resistance in neoplasm: Implications for systemic therapy. Cancer Res 44:3643-3653, 1984
35. Todeschini G, Tecchio C, Degani D, et al: Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: No differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol. Ann Oncol 8:77-81, 1997 (suppl 1)
36. Kantarjian H, O'Brien S, Keating MJ, et al: Update of the hyper-CVAD dose-intensive regimen in adult acute lymphocytic leukemia. Blood 92:313, 1998 (abstr 1285)
37. Philip T, Meckenstock R, Deconnick E, et al: Treatment of poor prognosis Burkitt's lymphoma in adults with the Societe Francaise d'Oncologie Pediatrique LMB protocol: A study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC). Eur J Cancer 28A:1954-1959, 1992
38. Sweetenham J, Pearce R, Taghipour G, et al: Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma: Outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse - Results from the European Group for Blood and Marrow Transplantation. J Clin Oncol 14:2465-2472, 1996
39. Sweetenham JW, Proctor SJ, Blaise D, et al: High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: The EBMT experience. Ann Oncol 5:S155-S159, 1994 (suppl 2)
40. Troussard X, Leblond V, Kuentz M, et al: Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission. J Clin Oncol 8:809-812, 1990